Vitala non-invasive continence control device demonstrates safety in Phase 2 clinical study

Vitala™ a novel, non-invasive continence control device, demonstrated safety and efficacy in providing up to 8 hours of temporary continence to people with an end colostomy, according to results of a study published in the journal Diseases of the Colon & Rectum.

Developed by ConvaTec, a world-leading developer of innovative medical technologies for community and hospital care, the Vitala™ Continence Control Device (CCD) allows individuals to manage their colostomy without a pouch, belt or irrigation.  The single-use, disposable disc-shaped device, which is worn together with the ConvaTec Natura® skin barrier (1-3/4" or 2-1/4"), is currently available in select European markets, where it is indicated for use up to 12 hours daily.

"People with a colostomy experience many challenges in adapting to life after surgery, often profoundly impacting their quality of life," said lead study investigator Terri Maxwell, RN, MSN, BC-FNP-C, CWOCN.  "After many years of seeking out better methods to help patients gain more control in managing their colostomies, with Vitala™ CCD we now have a technology that provides the temporary continence they need and deserve."

The innovative Vitala™ CCD functions by sealing against the stoma to prevent the uncontrolled release of stool while permitting gasses to vent through an integrated, deodorizing filter.  When in use, stool is stored inside the body, negating the need to wear an ostomy pouch.  The unique design of Vitala™ CCD not only eliminates the need for a pouch for an extended period of time each day, it also minimizes the noise and odors that occasionally accompany pouch use.  The discreet low profile device also helps make the presence of an ostomy less noticeable.  

The multi-center Phase 2 clinical study evaluated the safety and efficacy of the device when worn up to 8 hours a day by individuals with an end colostomy.  

After the study period of 142 days, results showed that there were no serious adverse events associated with wearing the device. Three participants reported adverse events that were considered related to device wear, none of which led to discontinuation from the study. Throughout the device wear stage, no changes to either stoma vascularity or gut microbiology were observed.

Participants in the study reported high levels of satisfaction with the device and its performance, with 87 percent rating the ability to restore continence as good or very good at the end of the study period.  Four out of five users (80 percent) reported no odor when wearing Vitala™ CCD and nearly three out of four (73.9 percent) reported less than usual stoma noise.   At the end of the study period, approximately two-thirds (65.2 percent) of participants, who had used pouching systems on average for more than six years, stated that the Vitala™ device was their preferred method of ostomy management.

"These promising Phase 2 results demonstrate the safety and efficacy of this novel approach to colostomy management, in providing temporary continence and alleviating colostomy-related concerns," added Maxwell.  "After the initial adjustment and once routinely wearing Vitala™ CCD, many of our participants actually became aware once again of when the bowel would need to move and they could act accordingly, much as people without a colostomy do."

Vitala™ CCD is recommended for use after a minimum of 6 weeks after surgery.  Full product use information is available in the package insert. Easy to apply and remove, the Vitala™ CCD contains a built-in expandable container to prevent soiling and odor during the removal process.  Vitala™ CCD is also waterproof, so it can be worn when bathing, showering or swimming.

"ConvaTec developed this breakthrough technology to give people with a colostomy regained control, more confidence and greater freedom," said Marcus Schabacker, Chief Scientific Officer of ConvaTec.  "As the authors conclude, Vitala™ CCD provides an important option for colostomy continence, which we believe should be considered a fundamental patient right, and we are committed to further demonstrating how this benefit can make a difference in people's lives."

SOURCE ConvaTec

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Researchers discover how Acinetobacter baumannii can survive on hospital surfaces without water